Basic Information
| RNALocate ID: | RLID:11003902 |
| RNA Symbol: | hsa-miR-340-5p |
| Localization: | Extracellular vesicle |
RNA Information
| RNA Name: | hsa-miR-340 |
| RNA ID: | miRBase:MIMAT0004692 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22849433 |
| Tissue/Cell Line: | HEK-293T cells |
| Method: | Next-generation RNA sequencing |
| Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002631 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11003895 | Exosome | Serum | 29143228 |
| RLID:11003896 | Exosome | Serum | 18589210 |
| RLID:11003897 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003898 | Exosome | Brain tissue | 23382797 |
| RLID:11003899 | Exosome | Plasma | 23663360 |
| RLID:11003900 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11003901 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID-D:11000198 | Exosome | Blood|Breast milk|Endothelial cells|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000664 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-340-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-41928 |
| MNDR | hsa-miR-340-5p | Rheumatic heart diseases | MNDR-E-MI-41929 |
| MNDR | hsa-miR-340-5p | Oral squamous cell carcinoma | MNDR-E-MI-41930 |
| MNDR | hsa-miR-340-5p | Medulloblastoma | MNDR-E-MI-41931 |
| MNDR | hsa-miR-340-5p | Lymphoma | MNDR-E-MI-41932 |
| MNDR | hsa-miR-340-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-41933 |
| MNDR | hsa-miR-340-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-41934 |
| MNDR | hsa-miR-340-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-41935 |
| MNDR | hsa-miR-340-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-41936 |
| MNDR | hsa-miR-340-5p | Her2-receptor positive breast cancer | MNDR-E-MI-41937 |
| MNDR | hsa-miR-340-5p | Triple negative breast cancer | MNDR-E-MI-41938 |
| MNDR | hsa-miR-340-5p | Breast cancer luminal | MNDR-E-MI-41939 |
| MNDR | hsa-miR-340-5p | Dermatomyositis | MNDR-E-MI-41940 |
| MNDR | hsa-miR-340-5p | Prostate cancer | MNDR-E-MI-41941 |
| MNDR | hsa-miR-340-5p | Gastric cancer | MNDR-E-MI-41942 |
| MNDR | hsa-miR-340-5p | Alzheimer disease | MNDR-E-MI-41943 |
| MNDR | hsa-miR-340-5p | Dysautonomia familial | MNDR-E-MI-41944 |
| MNDR | hsa-miR-340-5p | Huntington disease | MNDR-E-MI-41945 |
| MNDR | hsa-miR-340-5p | Cardiovascular disease | MNDR-E-MI-41946 |
| MNDR | hsa-miR-340-5p | Lung cancer | MNDR-E-MI-41947 |
| MNDR | hsa-miR-340-5p | Parkinson disease | MNDR-E-MI-41948 |
| MNDR | hsa-miR-340-5p | Basal-like breast cancer | MNDR-E-MI-41949 |
| MNDR | hsa-miR-340-5p | Thyroid cancer | MNDR-E-MI-41950 |
| MNDR | hsa-miR-340-5p | Pituitary neoplasms | MNDR-E-MI-41951 |
| MNDR | hsa-miR-340-5p | Pancreatic cancer | MNDR-E-MI-41952 |
| MNDR | hsa-miR-340-5p | Melanoma | MNDR-E-MI-41953 |
| MNDR | hsa-miR-340-5p | Colon cancer | MNDR-E-MI-41954 |
| MNDR | hsa-miR-340-5p | Colon adenocarcinoma | MNDR-E-MI-41955 |
| MNDR | hsa-miR-340-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-41956 |
| MNDR | hsa-miR-340-5p | Ovarian cancer | MNDR-E-MI-41957 |
| MNDR | hsa-miR-340-5p | Acromegaly | MNDR-E-MI-41958 |
| MNDR | hsa-miR-340-5p | Prostate adenocarcinoma | MNDR-E-MI-41959 |
| MNDR | hsa-miR-340-5p | Kidney cancer | MNDR-E-MI-41960 |
| MNDR | hsa-miR-340-5p | Carcinoma ductal breast | MNDR-E-MI-41961 |
| MNDR | hsa-miR-340-5p | Glioblastoma | MNDR-E-MI-41962 |
| MNDR | hsa-miR-340-5p | Glioma | MNDR-E-MI-41963 |
| MNDR | hsa-miR-340-5p | Neurilemmoma | MNDR-E-MI-41964 |
| MNDR | hsa-miR-340-5p | Central nervous system lymphoma | MNDR-E-MI-41965 |
| MNDR | hsa-miR-340-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-41966 |
| MNDR | hsa-miR-340-5p | Epilepsy temporal lobe | MNDR-E-MI-41967 |
| MNDR | hsa-miR-340-5p | Coronary artery disease | MNDR-E-MI-41968 |
| MNDR | hsa-miR-340-5p | Inclusion body myositis | MNDR-E-MI-41969 |
| MNDR | hsa-miR-340-5p | Breast carcinoma | MNDR-E-MI-41970 |
| MNDR | hsa-miR-340-5p | Uterine cancer | MNDR-E-MI-41971 |
| MNDR | hsa-miR-340-5p | Pituitary adenoma | MNDR-E-MI-41972 |
| MNDR | hsa-miR-340-5p | Lung squamous cell carcinoma | MNDR-E-MI-41973 |
| MNDR | hsa-miR-340-5p | Lung adenocarcinoma | MNDR-E-MI-41974 |
| MNDR | hsa-miR-340-5p | Adrenocortical carcinoma | MNDR-E-MI-41975 |
| MNDR | hsa-miR-340-5p | Bladder urothelial carcinoma | MNDR-E-MI-41976 |
| MNDR | hsa-miR-340-5p | Carcinoma renal cell | MNDR-E-MI-41977 |
| MNDR | hsa-miR-340-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-41978 |
| MNDR | hsa-miR-340-5p | Renal clear cell carcinoma | MNDR-E-MI-41979 |
| MNDR | hsa-miR-340-5p | Cholangiocarcinoma | MNDR-E-MI-41980 |
| MNDR | hsa-miR-340-5p | Esophageal cancer | MNDR-E-MI-41981 |
| MNDR | hsa-miR-340-5p | Liver cirrhosis | MNDR-E-MI-41982 |
| MNDR | hsa-miR-340-5p | Lung small cell carcinoma | MNDR-E-MI-41983 |
| MNDR | hsa-miR-340-5p | Synovial sarcoma | MNDR-E-MI-41984 |
| MNDR | hsa-miR-340-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-41985 |
| MNDR | hsa-miR-340-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-41986 |
| MNDR | hsa-miR-340-5p | Breast invasive carcinoma | MNDR-E-MI-41987 |
| MNDR | hsa-miR-340-5p | Early hepatocellular carcinoma | MNDR-E-MI-41988 |
| MNDR | hsa-miR-340-5p | Embryonal cancer | MNDR-E-MI-41989 |
| MNDR | hsa-miR-340-5p | Lymphoblastoid | MNDR-E-MI-41990 |
| MNDR | hsa-miR-340-5p | Rheumatoid arthritis | MNDR-E-MI-41991 |
| MNDR | hsa-miR-340-5p | Retinoblastoma | MNDR-E-MI-41992 |
| MNDR | hsa-miR-340-5p | Barrett's adenocarcinoma | MNDR-E-MI-41993 |
| MNDR | hsa-miR-340-5p | Hodgkin lymphoma | MNDR-E-MI-41994 |
| MNDR | hsa-miR-340-5p | Burkitt lymphoma | MNDR-E-MI-41995 |
| MNDR | hsa-miR-340-5p | Tonsil cancer | MNDR-E-MI-41996 |
| MNDR | hsa-miR-340-5p | Acute myeloid leukemia | MNDR-E-MI-41997 |
| MNDR | hsa-miR-340-5p | Colorectal cancer | MNDR-E-MI-41998 |
| MNDR | hsa-miR-340-5p | Nasopharynx carcinoma | MNDR-E-MI-41999 |
| MNDR | hsa-miR-340-5p | Multiple myeloma | MNDR-E-MI-42000 |
| MNDR | hsa-miR-340-5p | Nasopharyngeal cancer | MNDR-E-MI-42001 |
| MNDR | hsa-miR-340-5p | Stroke lacunar | MNDR-E-MI-42002 |
| MNDR | hsa-miR-340-5p | Barrett's carcinogenesis | MNDR-E-MI-42003 |
| MNDR | hsa-miR-340-5p | Breast cancer her3+ negative | MNDR-E-MI-42004 |
| MNDR | hsa-miR-340-5p | Low grade dysplastic nodule | MNDR-E-MI-42005 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCL11A | Homo sapiens | RR00218496 |
TOP